Flagship Pioneering CEO Noubar Afeyan at #JPM24 (Brian Benton Photography)
March 10, 2025 03:39 PM EDT
Startups
AI

New Flag­ship start­up aims to trail­blaze ‘AI sci­ence fac­to­ries’

Nicole DeFeudis

Editor

A new Flag­ship Pi­o­neer­ing start­up has emerged with $200 mil­lion and a team of ex­perts in both sci­ence and AI to pur­sue what it calls …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Vice President, Biology & Translational Research

Gondolabio

Palo Alto, CA, USA

TRENDING NOW

Beam shares promis­ing first clin­i­cal da­ta on gene edit­ing treat­ment for a lung and liv­er dis­ease 

Ex­clu­sive: FDA blocks drug and de­vice re­view­ers from tak­ing HH­S' buy­out of­fer

Tre­vi’s mid-stage chron­ic cough da­ta meet ‘home run’ sce­nario, stock soars

Sun Phar­ma to ac­quire Check­point Ther­a­peu­tics and its an­ti-PD-L1 an­ti­body

Emer­gent sells once-trou­bled man­u­fac­tur­ing site to In­di­an CD­MO

sponsored

Obe­si­ty drug de­vel­op­ment—still room to grow

A service from the Financial Times